Literature DB >> 9514938

GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains.

W M Kati1, A S Saldivar, F Mohamadi, H L Sham, W G Laver, W E Kohlbrenner.   

Abstract

The kinetics of inhibition of purified influenza neuraminidases from A/Tokyo/3/67 and B/Memphis/3/89 influenza viruses by (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene- 1-carboxylic acid (GS4071) were investigated. Progress curve experiments established that GS4071 is a time dependent inhibitor of both A and B strains of influenza neuraminidase. The apparent association and dissociation rate constants, as well as the overall Ki values, were only modestly different for the two neuraminidase strains. The time dependent inhibition phenomenon, often referred to as slow-binding inhibition, appears to be a consequence of the very slow rate of dissociation of the compound from influenza neuraminidase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514938     DOI: 10.1006/bbrc.1998.8282

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removal.

Authors:  Susan Barrett; Jennifer L McKimm-Breschkin
Journal:  Antiviral Res       Date:  2014-05-20       Impact factor: 5.970

2.  Effects of receptor binding specificity of avian influenza virus on the human innate immune response.

Authors:  Irene Ramos; Dabeiba Bernal-Rubio; Natasha Durham; Alan Belicha-Villanueva; Anice C Lowen; John Steel; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

Review 3.  Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.

Authors:  Jennifer L McKimm-Breschkin
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

4.  Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir.

Authors:  Michael Z Wang; Chun Y Tai; Dirk B Mendel
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.

Authors:  Akhteruzzaman Molla; Warren Kati; Robert Carrick; Kevin Steffy; Yan Shi; Debra Montgomery; Nanette Gusick; Vincent S Stoll; Kent D Stewart; Teresa I Ng; Clarence Maring; Dale J Kempf; William Kohlbrenner
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Novel alpha- and beta-amino acid inhibitors of influenza virus neuraminidase.

Authors:  W M Kati; D Montgomery; C Maring; V S Stoll; V Giranda; X Chen; W G Laver; W Kohlbrenner; D W Norbeck
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Investigation of the slow inhibition of almond beta-glucosidase and yeast isomaltase by 1-azasugar inhibitors: evidence for the 'direct binding' model.

Authors:  A Lohse; T Hardlei; A Jensen; I W Plesner; M Bols
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

8.  In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.

Authors:  Warren M Kati; Debra Montgomery; Robert Carrick; Larisa Gubareva; Clarence Maring; Keith McDaniel; Kevin Steffy; Akhteruzzaman Molla; Frederick Hayden; Dale Kempf; William Kohlbrenner
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

9.  Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses.

Authors:  Aaron J Oakley; Susan Barrett; Thomas S Peat; Janet Newman; Victor A Streltsov; Lynne Waddington; Takehiko Saito; Masato Tashiro; Jennifer L McKimm-Breschkin
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

10.  Pharmacokinetics and tolerability of oseltamivir combined with probenecid.

Authors:  Mark Holodniy; Scott R Penzak; Timothy M Straight; Richard T Davey; Kelvin K Lee; Matthew Bidwell Goetz; Dennis W Raisch; Francesca Cunningham; Emil T Lin; Noemi Olivo; Lawrence R Deyton
Journal:  Antimicrob Agents Chemother       Date:  2008-06-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.